Vasoconstriction is the narrowing of a blood vessel caused primarily by contraction of vascular smooth muscle. It reduces vessel radius, increases vascular resistance, and helps regulate arterial pressure, regional blood flow, venous return, and thermoregulation.
Vasoconstriction is the narrowing of a blood vessel, usually caused by contraction of vascular smooth muscle within the vessel wall. It occurs most prominently in arteries, arterioles, and veins that contain smooth muscle capable of actively changing vascular diameter.
Vasoconstriction is a fundamental mechanism of cardiovascular regulation. By decreasing vessel radius, it can increase vascular resistance, redistribute blood flow, support arterial pressure, alter venous capacitance, and regulate heat loss from the body.
The degree of vasoconstriction is controlled by interactions among the autonomic nervous system, circulating hormones, endothelial signals, local metabolites, mechanical forces, and intrinsic properties of vascular smooth muscle.
Vascular smooth muscle is located primarily within the tunica media of blood vessel walls.
Contraction of these smooth muscle cells decreases the internal diameter of the vessel, while relaxation allows the vessel to widen.
The ability to actively constrict varies among different types of blood vessels.
Arteries and arterioles have well-developed smooth muscle layers, while capillaries lack a continuous smooth muscle coat and therefore do not constrict in the same manner.
| Vessel Type | Effect of Vasoconstriction |
|---|---|
| Large arteries | Changes arterial diameter and vascular properties |
| Small arteries | Increases regional vascular resistance |
| Arterioles | Strongly regulates tissue blood flow and peripheral resistance |
| Veins | Reduces venous capacitance and can increase venous return |
Arterioles are major resistance vessels of the systemic circulation.
Constriction of arteriolar smooth muscle decreases lumen radius and can markedly increase resistance to blood flow.
Resistance to laminar flow is strongly dependent on vessel radius.
According to the principles represented by Poiseuille's relationship, resistance varies approximately inversely with the fourth power of radius under idealized conditions.
This means that relatively small decreases in arteriolar radius can produce large increases in resistance.
Blood flow through a vascular bed depends on the pressure gradient and vascular resistance.
A simplified relationship is:
Flow = Pressure Difference ÷ Resistance
If the pressure gradient remains constant, vasoconstriction that increases resistance reduces blood flow through that vascular bed.
Widespread constriction of systemic resistance vessels increases total peripheral resistance, also called systemic vascular resistance.
This can contribute to an increase in arterial pressure when other hemodynamic variables are considered.
Mean arterial pressure is related to cardiac output and systemic vascular resistance.
A simplified relationship is:
Mean Arterial Pressure − Right Atrial Pressure ≈ Cardiac Output × Systemic Vascular Resistance
Widespread arteriolar vasoconstriction can therefore help support arterial pressure by increasing systemic vascular resistance.
The sympathetic nervous system is a major neural regulator of vascular tone.
Many systemic blood vessels receive sympathetic vasoconstrictor fibers that allow rapid adjustment of vessel diameter.
Sympathetic nerve endings commonly release norepinephrine.
Norepinephrine binds to adrenergic receptors on vascular smooth muscle and commonly promotes contraction in vessels where alpha-adrenergic effects predominate.
Alpha-1 adrenergic receptors are important mediators of sympathetic vasoconstriction in many systemic vessels.
Activation of these receptors initiates intracellular signaling that increases smooth muscle contraction.
Many vascular beds receive a baseline level of sympathetic activity known as sympathetic vasoconstrictor tone.
Increasing this activity produces greater constriction, while reducing sympathetic activity permits relative vasodilation.
The baroreceptor reflex rapidly adjusts sympathetic vascular tone in response to changes in arterial pressure.
Stretch-sensitive receptors in the carotid sinus and aortic arch provide information about arterial pressure to cardiovascular control centers in the brainstem.
When arterial pressure falls, baroreceptor firing decreases.
This promotes increased sympathetic activity, producing arteriolar and venous vasoconstriction that helps restore circulatory pressure.
When arterial pressure rises, baroreceptor firing increases.
Sympathetic vasoconstrictor activity is reduced, allowing resistance vessels to relax and helping return pressure toward its previous level.
Constriction of veins is often called venoconstriction.
Because veins function as capacitance vessels and contain a large proportion of the circulating blood volume, venoconstriction can shift blood toward the central circulation.
Sympathetic venoconstriction decreases venous capacitance and can increase the pressure driving blood toward the heart.
This can increase venous return, ventricular filling, and cardiac output under appropriate physiological conditions.
Several circulating hormones can promote vasoconstriction.
Important examples include angiotensin II, vasopressin, norepinephrine, and epinephrine under receptor-specific conditions.
Angiotensin II is a potent vasoconstrictor formed through the renin-angiotensin system.
It acts on vascular smooth muscle and contributes to regulation of systemic vascular resistance and arterial pressure.
Reduced renal perfusion, reduced sodium chloride delivery to the macula densa, and sympathetic stimulation can promote renin release from the kidney.
Renin initiates a sequence that ultimately produces angiotensin II, which causes vasoconstriction and also stimulates mechanisms that promote sodium and water retention.
Vasopressin, also known as antidiuretic hormone, can cause vascular smooth muscle contraction through V1 receptors.
Its vasoconstrictor effects become particularly relevant at elevated circulating concentrations.
Epinephrine can produce either vasoconstrictor or vasodilator effects depending on concentration, receptor distribution, and vascular bed.
Alpha-adrenergic effects promote vasoconstriction, while beta-2 adrenergic effects can promote vasodilation in selected tissues.
Endothelial cells release substances that can either relax or contract vascular smooth muscle.
The balance between these endothelial signals contributes to local vascular tone.
Endothelin is a potent vasoconstrictor peptide produced by endothelial cells.
It can produce sustained contraction of vascular smooth muscle and participates in physiological and pathological regulation of vascular tone.
Nitric oxide is an important endothelium-derived vasodilator that opposes vasoconstrictor influences.
Reduced nitric oxide availability can shift the balance of vascular tone toward greater constriction.
Vascular smooth muscle contraction depends on an increase in intracellular calcium concentration.
Calcium binds to calmodulin, and the calcium-calmodulin complex activates myosin light-chain kinase.
Myosin light-chain kinase (MLCK) phosphorylates regulatory myosin light chains.
This permits interaction between myosin and actin, producing smooth muscle contraction and narrowing of the vessel.
Intracellular calcium can increase through entry from the extracellular fluid and release from intracellular stores.
The relative contribution depends on the receptor and signaling pathway responsible for the vasoconstrictor response.
Many vasoconstrictor receptors are G-protein-coupled receptors.
Activation of pathways involving phospholipase C, inositol trisphosphate, and intracellular calcium release can promote vascular smooth muscle contraction.
Vascular tone can also change through alterations in the sensitivity of the contractile apparatus to calcium.
Signaling pathways such as Rho kinase can enhance smooth muscle contraction without requiring a proportionate increase in intracellular calcium concentration.
Vascular smooth muscle can respond directly to increased stretch caused by elevated intravascular pressure.
In many resistance vessels, increased pressure triggers contraction. This myogenic response contributes to local autoregulation of blood flow.
Autoregulation allows some organs to maintain relatively stable blood flow despite changes in perfusion pressure.
When pressure increases, myogenic vasoconstriction can increase resistance and limit the increase in flow.
Local tissue metabolism often opposes vasoconstriction when oxygen and nutrient demand rises.
Accumulation of vasodilator metabolites can relax resistance vessels and increase local perfusion despite systemic vasoconstrictor influences.
During exercise, active skeletal muscle generates strong local vasodilator signals.
These local influences can attenuate sympathetic vasoconstriction within active muscle, allowing blood flow to increase despite generalized sympathetic activation.
Vasoconstriction is an important mechanism of body temperature regulation.
Constriction of cutaneous blood vessels reduces blood flow near the body surface and decreases heat transfer from the core to the environment.
Exposure to cold increases sympathetic vasoconstrictor activity in the skin.
The resulting reduction in cutaneous blood flow helps conserve body heat.
Cutaneous vascular resistance can change substantially according to thermoregulatory requirements.
During cold stress, increased resistance reduces skin perfusion. During heat stress, reduced vasoconstrictor tone and active vasodilator mechanisms can increase skin blood flow.
Blood loss reduces circulating volume, venous return, and arterial pressure.
Baroreceptor-mediated sympathetic activation produces vasoconstriction that helps preserve pressure and redirect blood toward vital organs.
Vasoconstriction does not occur equally in all vascular beds.
Selective changes in resistance allow the circulation to redistribute cardiac output according to physiological priorities.
During exercise, sympathetic activity increases throughout the cardiovascular system.
Vasoconstriction in some vascular beds helps redistribute blood, while strong local metabolic vasodilation in active skeletal muscle markedly increases muscle perfusion.
Renal vascular resistance is regulated by sympathetic activity, angiotensin II, local mediators, and intrinsic autoregulatory mechanisms.
Strong sympathetic activation can constrict renal vessels and reduce renal blood flow.
The gastrointestinal and other splanchnic vascular beds receive substantial sympathetic vasoconstrictor innervation.
During severe stress or exercise, increased resistance in these vessels can contribute to redistribution of blood toward other tissues.
Cerebral vascular tone is strongly influenced by local metabolic and chemical factors.
Systemic sympathetic influences generally play a more limited role in moment-to-moment cerebral blood flow than local autoregulatory mechanisms.
Coronary blood flow is strongly regulated by myocardial metabolic demand.
Local metabolic vasodilation usually dominates when cardiac work increases, ensuring increased oxygen delivery to the myocardium.
Contractile smooth muscle at the entrances to some capillary pathways can influence microvascular perfusion.
Changes in upstream arteriolar tone and precapillary control determine how much blood enters individual capillary networks.
Arteriolar vasoconstriction reduces the transmission of arterial pressure into downstream capillaries.
This can decrease capillary hydrostatic pressure and influence filtration of fluid into the interstitial space.
Widespread systemic arteriolar vasoconstriction increases systemic vascular resistance.
This can increase the load against which the left ventricle ejects, contributing to increased ventricular afterload.
When systemic resistance rises substantially, the left ventricle may need to generate greater pressure to eject blood.
This can increase myocardial workload and oxygen demand.
| Feature | Vasoconstriction | Vasodilation |
|---|---|---|
| Vessel radius | Decreases | Increases |
| Vascular smooth muscle | Contracts | Relaxes |
| Local resistance | Increases | Decreases |
| Local flow at constant pressure gradient | Decreases | Increases |
| Widespread systemic effect | Can increase SVR | Can decrease SVR |
Persistent increases in vascular tone can contribute to elevated systemic vascular resistance and arterial pressure.
Long-term hypertension involves complex interactions among vascular, renal, neural, endocrine, and structural mechanisms.
Vasoconstriction is an important compensatory response in several forms of circulatory shock.
Sympathetic activation can increase systemic vascular resistance and support arterial pressure when circulating volume or cardiac output falls.
In hypovolemic shock, loss of circulating volume activates sympathetic vasoconstriction.
This response helps maintain perfusion pressure and preferentially preserves blood flow to critical organs.
Severe reduction in cardiac output commonly triggers compensatory systemic vasoconstriction.
Although this may support arterial pressure, the resulting increase in afterload can place additional stress on the failing ventricle.
Septic shock can involve profound loss of normal vascular tone and widespread vasodilation.
Vasoconstrictor medications may be required in selected patients to restore adequate vascular tone and perfusion pressure.
Raynaud phenomenon involves episodic excessive vasoconstriction of vessels supplying the digits, commonly triggered by cold exposure or emotional stress.
The reduced blood flow produces characteristic changes in skin color and sensation.
Transient excessive constriction of a coronary artery can markedly reduce myocardial blood flow.
Coronary vasospasm can produce myocardial ischemia even in the absence of a fixed severe arterial obstruction.
Pathological constriction of cerebral arteries can reduce blood flow to brain tissue.
Cerebral vasospasm is particularly important in certain neurological conditions, including after subarachnoid hemorrhage.
Vasopressors are medications used to increase vascular tone and support arterial pressure in selected forms of severe hypotension or shock.
Different vasopressors act through different adrenergic or nonadrenergic receptor systems.
Although vasoconstriction can preserve systemic pressure, excessive constriction can reduce tissue perfusion.
Prolonged or severe reduction in regional blood flow can contribute to tissue ischemia and organ dysfunction.
| Influence | Mechanism |
|---|---|
| Sympathetic norepinephrine | Alpha-adrenergic receptor activation |
| Angiotensin II | Direct vascular smooth muscle contraction |
| Vasopressin | V1 receptor-mediated contraction |
| Endothelin | Endothelin receptor-mediated smooth muscle contraction |
| Myogenic response | Contraction in response to increased vascular stretch |
| Feature | Key Point |
|---|---|
| Definition | Narrowing of blood vessels through vascular smooth muscle contraction |
| Major site | Small arteries and arterioles for resistance regulation |
| Radius | Decreases |
| Resistance | Increases |
| Local blood flow | Usually decreases when the pressure gradient is unchanged |
| Major neural regulator | Sympathetic nervous system |
| Major receptor | Alpha-1 adrenergic receptor in many systemic vessels |
| Systemic role | Supports arterial pressure and redistributes blood flow |
| Venous role | Reduces venous capacitance and can increase venous return |
Vasoconstriction allows the cardiovascular system to regulate vascular resistance rapidly and selectively. Constriction of arterioles controls the amount of blood entering tissue microcirculations, while constriction of veins alters the distribution of blood between peripheral capacitance vessels and the central circulation.
Sympathetic neural activity provides rapid systemic control, while hormones such as angiotensin II and vasopressin can reinforce vascular contraction. Local metabolic and endothelial signals modify these influences so that tissue perfusion can be matched to regional physiological requirements.
Through these mechanisms, vasoconstriction contributes to maintenance of arterial pressure, redistribution of cardiac output, regulation of capillary pressure, venous return, thermoregulation, and cardiovascular responses to exercise, hemorrhage, posture, and stress.